160 related articles for article (PubMed ID: 10427623)
21. The systemic lupus erythematosus (SLE) disease autoantigen-calreticulin can inhibit C1q association with immune complexes.
Kishore U; Sontheimer RD; Sastry KN; Zappi EG; Hughes GR; Khamashta MA; Reid KB; Eggleton P
Clin Exp Immunol; 1997 May; 108(2):181-90. PubMed ID: 9158084
[TBL] [Abstract][Full Text] [Related]
22. Anti C1q antibodies in cutaneous lupus erythematosus.
Bălănescu E; Tănăsescu C; Bălănescu P; Olteanu R; Badea C; Petruţescu B; Grancea C; Vagu C; Bleotu C; Ruţă S; Ardeleanu C
Rom J Intern Med; 2010; 48(2):159-63. PubMed ID: 21428180
[TBL] [Abstract][Full Text] [Related]
23. Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation.
Nielsen CT; Østergaard O; Stener L; Iversen LV; Truedsson L; Gullstrand B; Jacobsen S; Heegaard NH
Arthritis Rheum; 2012 Apr; 64(4):1227-36. PubMed ID: 22238051
[TBL] [Abstract][Full Text] [Related]
24. Autoantibodies to the collagen-like region of C1q are strongly associated with classical pathway-mediated hypocomplementemia in systemic lupus erythematosus.
Frémeaux-Bacchi V; Weiss L; Demouchy C; Blouin J; Kazatchkine MD
Lupus; 1996 Jun; 5(3):216-20. PubMed ID: 8803893
[TBL] [Abstract][Full Text] [Related]
25. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
Antes U; Heinz HP; Loos M
J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
[TBL] [Abstract][Full Text] [Related]
26. Detection of autoantibodies against the globular domain of human C1q in the sera of systemic lupus erythematosus patients.
Tsacheva I; Radanova M; Todorova N; Argirova T; Kishore U
Mol Immunol; 2007 Mar; 44(8):2147-51. PubMed ID: 17049989
[TBL] [Abstract][Full Text] [Related]
27. Autoreactivity to mouse C1q in a murine model of SLE.
Trinder PK; Maeurer MJ; Schorlemmer HU; Loos M
Rheumatol Int; 1995; 15(3):117-20. PubMed ID: 8588121
[TBL] [Abstract][Full Text] [Related]
28. A method to differentiate between anti-C1q antibodies and C1q-binding immune complexes using collagenase-digested solid phase C1q.
Menzel JE; Scherak O; Kolarz G; Gamerith F; Youngchaiyud U
J Immunol Methods; 1991 Apr; 138(2):165-71. PubMed ID: 1851794
[TBL] [Abstract][Full Text] [Related]
29. Anti-C1q autoantibodies specific against the globular domain of the C1qB-chain from patient with lupus nephritis inhibit C1q binding to IgG and CRP.
Radanova M; Vasilev V; Deliyska B; Kishore U; Ikonomov V; Ivanova D
Immunobiology; 2012 Jul; 217(7):684-91. PubMed ID: 22209113
[TBL] [Abstract][Full Text] [Related]
30. Relevance of anti-C1q autoantibodies to lupus nephritis.
Tsirogianni A; Pipi E; Soufleros K
Ann N Y Acad Sci; 2009 Sep; 1173():243-51. PubMed ID: 19758158
[TBL] [Abstract][Full Text] [Related]
31. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
Zhang FC; Zhou B; Dong Y
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001
[TBL] [Abstract][Full Text] [Related]
32. Functional definition of a B cell epitope, KGEQGEPGA, on C1q the Fc-binding subunit of the first component of complement.
Trinder PK; Märker-Hermann E; Loos M; Maeurer MJ
Scand J Immunol; 1999 Dec; 50(6):635-41. PubMed ID: 10607312
[TBL] [Abstract][Full Text] [Related]
33. The effect of high salt concentration on detection of serum immune complexes and autoantibodies to C1q in patients with systemic lupus erythematosus.
Kohro-Kawata J; Wener MH; Mannik M
J Rheumatol; 2002 Jan; 29(1):84-9. PubMed ID: 11824976
[TBL] [Abstract][Full Text] [Related]
34. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
35. Tests for circulating immune complexes.
Wener MH
Methods Mol Biol; 2014; 1134():47-57. PubMed ID: 24497353
[TBL] [Abstract][Full Text] [Related]
36. IgG autoantibodies to C1q do not detectably influence complement activation in vivo and in vitro in systemic lupus erythematosus.
Siegert CE; Daha MR; Lobatto S; van der Voort EA; Breedveld FC
Immunol Res; 1992; 11(2):91-7. PubMed ID: 1431425
[TBL] [Abstract][Full Text] [Related]
37. Complement and systemic lupus erythematosus.
Walport MJ
Arthritis Res; 2002; 4 Suppl 3(Suppl 3):S279-93. PubMed ID: 12110148
[TBL] [Abstract][Full Text] [Related]
38. C1q-binding immunoglobulin G in MRL/l mice consists of immune complexes containing antibodies to DNA.
Uwatoko S; Mannik M; Oppliger IR; Okawa-Takatsuji M; Aotsuka S; Yokohari R; Seki G; Taniguchi S; Suzuki K; Kurokawa K
Clin Immunol Immunopathol; 1995 May; 75(2):140-6. PubMed ID: 7704971
[TBL] [Abstract][Full Text] [Related]
39. Significance of complement components C1q and C4 bound to circulating immune complexes in juvenile idiopathic arthritis: support for classical complement pathway activation.
Gilliam BE; Reed MR; Chauhan AK; Dehlendorf AB; Moore TL
Clin Exp Rheumatol; 2011; 29(6):1049-56. PubMed ID: 22153664
[TBL] [Abstract][Full Text] [Related]
40. Western blot analysis of human IgG reactive with the collagenous portion of C1q: evidence of distinct binding specificities.
Mårtensson U; Sjöholm AG; Sturfelt G; Truedsson L; Laurell AB
Scand J Immunol; 1992 Jun; 35(6):735-44. PubMed ID: 1604245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
